SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013178
Filing Date
2022-08-11
Accepted
2022-08-11 07:18:57
Documents
65
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q thrx-20220630x10q.htm   iXBRL 10-Q 1426915
2 EX-3.1 thrx-20220630xex3d1.htm EX-3.1 63112
3 EX-3.2 thrx-20220630xex3d2.htm EX-3.2 242200
4 EX-31.1 thrx-20220630xex31d1.htm EX-31.1 15019
5 EX-31.2 thrx-20220630xex31d2.htm EX-31.2 15234
6 EX-32.1 thrx-20220630xex32d1.htm EX-32.1 8026
7 EX-32.2 thrx-20220630xex32d2.htm EX-32.2 8019
8 GRAPHIC thrx-20220630xex3d2001.jpg GRAPHIC 5053
  Complete submission text file 0001558370-22-013178.txt   6120513

Data Files

Seq Description Document Type Size
9 EX-101.SCH thrx-20220630.xsd EX-101.SCH 32974
10 EX-101.CAL thrx-20220630_cal.xml EX-101.CAL 37825
11 EX-101.DEF thrx-20220630_def.xml EX-101.DEF 165653
12 EX-101.LAB thrx-20220630_lab.xml EX-101.LAB 362603
13 EX-101.PRE thrx-20220630_pre.xml EX-101.PRE 288256
59 EXTRACTED XBRL INSTANCE DOCUMENT thrx-20220630x10q_htm.xml XML 943314
Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Filer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40869 | Film No.: 221153676
SIC: 2834 Pharmaceutical Preparations